Stereotaxis and Philips Extend Development Collaboration to Interface Latest Systems
ST. LOUIS and BEST, The Netherlands, Jan. 26, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS) today announced Stereotaxis and Philips have signed an addendum pursuant to their existing Development and Cooperation Agreement to facilitate development of a new interface between each company’s most advanced systems for electrophysiology (EP) and interventional cardiology procedures. The new interface will enable interoperability of Stereotaxis’ Niobe® ES remote magnetic navigation system with the latest version of Philips’ cardiovascular X-ray system, Allura Xper FD10*. This new interface is expected to be available in major global markets in 2016.
“The new interface between our Niobe ES system and the latest generation cardiovascular X-ray system from one of the imaging industry’s leaders will be a powerful combination of products for our customers,” said William C. Mills, Stereotaxis Chief Executive Officer. “We have been aligned with Philips for more than a decade in delivering cutting-edge solutions that ensure effective procedures while optimizing clinician comfort and efficiency in the cardiac cath lab. Partnering with industry leaders to develop key enabling solutions has been an integral part of our ongoing commitment to evolving our magnetic navigation platform for improved performance.”
“As one of the leading system integrators in image-guided therapies, we are collaborating with industrial partners to complement our portfolio of interventional imaging, devices and navigation solutions,” said Ronald Tabaksblat, Business Leader Image-Guided Therapy Systems at Philips. “The collaboration with Stereotaxis broadens our ability to provide our customers with advanced imaging and navigation solutions for electrophysiology procedures that are seamlessly integrated into our interventional labs with the aim to make such procedures more effective and easier to perform.”
The latest release of the Philips’ Allura Xper FD10 system is a ceiling-suspended cardiovascular X-ray system widely used for EP and other cardiac interventions. The system offers rotational scan capabilities to produce high-resolution, 3D impressions of cardiac anatomy. It features low dose X-ray, storage and retrieval of multi-modality cardiology information from a central workstation, and high quality visualization of the position of catheters in real-time.
About Stereotaxis
Stereotaxis is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. Over 100 issued patents support the Stereotaxis platform, which helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Stereotaxis' core Epoch® Solution includes the Niobe® ES remote magnetic navigation system, the Odyssey® portfolio of lab optimization, networking and patient information management systems, and the Vdrive® robotic navigation system and consumables.
The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Canada, China, Japan, and elsewhere. The V-Sono™ ICE catheter manipulator, V-Loop™ variable loop catheter manipulator, and V-CAS™ catheter advancement system have received clearance in the United States, Canada, and the European Union. For more information, please visit www.stereotaxis.com.